These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24503807)

  • 1. Accreditation for excellence of cancer research institutes: recommendations from the Italian Network of Comprehensive Cancer Centers.
    Deriu PL; La Pietra L; Pierotti M; Collazzo R; Paradiso A; Belardelli F; De Paoli P; Nigro A; Lacalamita R; Ferrarini M; Pelicci P; Pierotti M; Roli A; Ciliberto G; Scala S; Amadori A; Chiusole D; Musto P; Fusco V; Storto G; De Maria R; Canitano S; Apolone G; Ravelli M; Mazzini E; Amadori D; Bernabini M; Ancarani V; Lombardo C
    Tumori; 2013; 99(6):293e-8e. PubMed ID: 24503807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The European accreditation of Istituto Tumori Giovanni Paolo II of Bari.
    Lacalamita R; Quaranta A; Trisorio Liuzzi MP; Nigro A; Simonetti U; Schirone M; Aloè F; Capochiani G; De Francesco G; Gadaleta C; Galetta D; Grammatica L; Guarini A; Mattioli V; Milella P; Moschetta A; Nardulli P; Nigro V; Silvestris N; Paradiso A
    Tumori; 2015; 101 Suppl 1():S14-8. PubMed ID: 27096266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of OECI accreditation program to cancer institutes of the Alleanza Contro il Cancro Italian Network: a special project supported by the Italian Ministry of Health.
    Paradiso A; Belardelli F
    Tumori; 2015; 101 Suppl 1():S2-5. PubMed ID: 27096264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OECI accreditation of the European Institute of Oncology of Milan: strengths and weaknesses.
    Deriu PL; Basso S; Mastrilli F; Orecchia R
    Tumori; 2015; 101 Suppl 1():S21-4. PubMed ID: 27096268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation of Italian Cancer Centres of the Alleanza Contro Il Cancro (ACC) in the Organisation of European Cancer Institutes (OECI) Accreditation and Designation program: a successful first national initiative.
    Oberst S; Boomsma F; Lombardo C; Docter M; Blaauwgeers H; De Paoli P; de Valeriola D; Paradiso A; Saghatchian M
    Tumori; 2015; 101 Suppl 1():S6-9. PubMed ID: 27098181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alleanza Contro il Cancro: the accreditation system of the Excellence Network of Italian Cancer Centers in the precision medicine era.
    Palombo F; De Paoli P; De Maria R
    Tumori; 2015; 101 Suppl 1():S64-6. PubMed ID: 27096277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The experience of accreditation of the Reggio Emilia Research Hospital with the OECI model.
    Mazzini E; Cerullo L; Mazzi G; Costantini M
    Tumori; 2015; 101 Suppl 1():S42-6. PubMed ID: 27096272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards quality, comprehensiveness and excellence. The accreditation project of the Organisation of European Cancer Institutes (OECI).
    Saghatchian M; Hummel H; Otter R; de Valeriola D; Van Harten W; Paradiso A; Koot B; Ringborg U; Tursz T;
    Tumori; 2008; 94(2):164-71. PubMed ID: 18564602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Comprehensive Cancer Care Network of Romagna: the opportunities generated by the OECI accreditation program.
    Ancarani V; Bernabini M; Zani C; Altini M; Amadori D
    Tumori; 2015; 101 Suppl 1():S55-9. PubMed ID: 27096275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Regina Elena National Cancer Institute process of accreditation according to the standards of the Organisation of European Cancer Institutes.
    Canitano S; Di Turi A; Caolo G; Pignatelli AC; Papa E; Branca M; Cerimele M; De Maria R
    Tumori; 2015; 101 Suppl 1():S51-4. PubMed ID: 27096274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of accreditation for cancer patients: from end users to partners.
    Florindi F; De Lorenzo F
    Tumori; 2015; 101 Suppl 1():S60-3. PubMed ID: 27096276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioneering quality assessment in European cancer centers: a data analysis of the organization for European cancer institutes accreditation and designation program.
    Saghatchian M; Thonon F; Boomsma F; Hummel H; Koot B; Harrison C; Rajan A; de Valeriola D; Otter R; Laranja Pontes J; Lombardo C; McGrath E; Ringborg U; Tursz T; van Harten W
    J Oncol Pract; 2014 Sep; 10(5):e342-9. PubMed ID: 25118210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health systems, quality of health care, and translational cancer research: the role of the Istituto Superiore Sanità - Rome.
    Ricciardi W
    Tumori; 2015; 101 Suppl 1():S67-8. PubMed ID: 27096278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The OECI model: the CRO Aviano experience.
    Da Pieve L; Collazzo R; Masutti M; De Paoli P
    Tumori; 2015; 101 Suppl 1():S10-3. PubMed ID: 27096265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achievement of European standards by CROB-IRCCS.
    Gallicchio R; Scapicchio D; Musto P; Storto G
    Tumori; 2015; 101 Suppl 1():S47-50. PubMed ID: 27096273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The organization of clinical trials for oncology at IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale" Napoli and the impact of the OECI accreditation process.
    De Feo G; D'Ambrosio F; Palmieri G; Perrone F; Ciliberto G
    Tumori; 2015; 101 Suppl 1():S33-7. PubMed ID: 27096270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a benchmark tool for cancer centers; results from a pilot exercise.
    Wind A; van Dijk J; Nefkens I; van Lent W; Nagy P; Janulionis E; Helander T; Rocha-Goncalves F; van Harten W
    BMC Health Serv Res; 2018 Oct; 18(1):764. PubMed ID: 30305057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OECI accreditation at Veneto Institute of Oncology IOV -- IRCCS, general framework and multidisciplinary approach.
    Chiusole D; Cioffredi P; Basso U; Bortolami A; Crivellari G; Gennaro G; Spina R; Opocher G
    Tumori; 2015; 101 Suppl 1():S38-41. PubMed ID: 27096271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.